EVOK EVOKE PHARMA INC Capital Structure Changes 8-K Filing 2024 - Nasdaq Listing Rule Compliance Evoke Pharma announced that the Nasdaq Hearings Panel has granted the company's request to continue its listing on the Nasdaq Capital Market, subject to compliance with stockholders equity requirement.Get access to all SEC 8-K filings of the EVOKE PHARMA INC